serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.400 Multiple Endocrine Neoplasia .
C04.588.322.400.505 Multiple Endocrine Neoplasia Type 2a .
C04.651 Neoplasms, Multiple Primary .
C04.651.600 Multiple Endocrine Neoplasia .
C04.651.600.505 Multiple Endocrine Neoplasia Type 2a .
C04.700 Neoplastic Syndromes, Hereditary .
C04.700.630 Multiple Endocrine Neoplasia .
C04.700.630.505 Multiple Endocrine Neoplasia Type 2a .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.700 Neoplastic Syndromes, Hereditary .
C16.320.700.630 Multiple Endocrine Neoplasia .
C16.320.700.630.505 Multiple Endocrine Neoplasia Type 2a .
C19 Endocrine System Diseases .
C19.344 Endocrine Gland Neoplasms .
C19.344.400 Multiple Endocrine Neoplasia .
C19.344.400.505 Multiple Endocrine Neoplasia Type 2a .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.656 Peptide Hydrolases .
D08.811.277.656.262 Cysteine Proteases .
D08.811.277.656.262.500 Cysteine Endopeptidases .
D08.811.277.656.262.500.120 Calpain .
D08.811.277.656.300 Endopeptidases .
D08.811.277.656.300.200 Cysteine Endopeptidases .
D08.811.277.656.300.200.120 Calpain .
D08.811.913 Transferases .
D08.811.913.050 Acyltransferases .
D08.811.913.050.350 Carnitine Acyltransferases .
D08.811.913.050.350.200 Carnitine O-Palmitoyltransferase .
D08.811.913.696 Phosphotransferases .
D08.811.913.696.620 Phosphotransferases (Alcohol Group Acceptor) .
D08.811.913.696.620.682 Protein Kinases .
D08.811.913.696.620.682.700 Protein-Serine-Threonine Kinases .
D08.811.913.696.620.682.700.150 Cyclic Nucleotide-Regulated Protein Kinases .
D08.811.913.696.620.682.700.150.150 Cyclic GMP-Dependent Protein Kinases .
D08.811.913.696.620.682.700.150.150.750 Cyclic GMP-Dependent Protein Kinase Type II .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.360 Intracellular Signaling Peptides and Proteins .
D12.644.360.200 Cyclic Nucleotide-Regulated Protein Kinases .
D12.644.360.200.150 Cyclic GMP-Dependent Protein Kinases .
D12.644.360.200.150.750 Cyclic GMP-Dependent Protein Kinase Type II .
D12.776 Proteins .
D12.776.157 Carrier Proteins .
D12.776.157.125 Calcium-Binding Proteins .
D12.776.157.125.050 Annexins .
D12.776.157.125.050.050 Annexin A1 .
D12.776.476 Intracellular Signaling Peptides and Proteins .
D12.776.476.200 Cyclic Nucleotide-Regulated Protein Kinases .
D12.776.476.200.150 Cyclic GMP-Dependent Protein Kinases .
D12.776.476.200.150.750 Cyclic GMP-Dependent Protein Kinase Type II .
F04 Behavioral Disciplines and Activities .
F04.711 Psychological Tests .
F04.711.513 Neuropsychological Tests .
L01 Information Science .
L01.453 Information Services .
L01.453.245 Documentation .
L01.453.245.945 Vocabulary, Controlled .
L01.453.245.945.160 Current Procedural Terminology .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Carnitine O-Palmitoyltransferase .
CPT II .
Carnitine Acyltransferase I .
Carnitine Palmitoyltransferase I .
Carnitine Palmitoyltransferase II .
Palmitoylcarnitine Transferase .
Palmitylcarnitine Acyltransferase .
Acyltransferase I, Carnitine .
Acyltransferase, Palmitylcarnitine .
Carnitine O Palmitoyltransferase .
II, Carnitine Palmitoyltransferase .
O-Palmitoyltransferase, Carnitine .
Palmitoyltransferase I, Carnitine .
Palmitoyltransferase II, Carnitine .
Palmitoyltransferase, Carnitine .
Transferase, Palmitoylcarnitine .
Carnitine Palmitoyltransferase .
An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21. .
1.00
 
Current Procedural Terminology .
Current Procedural Terminology Codes .
CPT Code .
Code, CPT .
Codes, CPT .
CPT Codes .
Descriptive terms and identifying codes for reporting medical services and procedures performed by PHYSICIANS. It is produced by the AMERICAN MEDICAL ASSOCIATION and used in insurance claim reporting for MEDICARE; MEDICAID; and private health insurance programs (From CPT 2002). .
0.59
 
Neuropsychological Tests .
AX-CPT .
Behavioral Assessment of Dysexecutive Syndrome .
CANTAB .
Cambridge Neuropsychological Test Automated Battery .
Clock Test .
Cognitive Function Scanner .
Continuous Performance Task .
Controlled Oral Word Association Test .
Delis-Kaplan Executive Function System .
Developmental Neuropsychological Assessment .
Hooper Visual Organization Test .
NEPSY .
Neuropsychologic Tests .
Neuropsychological Test .
Paced Auditory Serial Addition Test .
Repeatable Battery for the Assessment of Neuropsychological Status .
Rey-Osterrieth Complex Figure .
Symbol Digit Modalities Test .
Test of Everyday Attention .
Test, Neuropsychological .
Tests, Neuropsychological .
Tower of London Test .
Neuropsychologic Test .
Aphasia Tests .
Memory for Designs Test .
Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. .
0.52
 
Calpain .
Ca2+-Activated Protease .
Calcium-Activated Neutral Proteinase .
Calcium-Activated Protease .
Calcium-Dependent Neutral Protease .
Calpain I .
Calpain II .
Desminase .
Ca2+ Activated Protease .
Calcium Activated Neutral Protease .
Calcium Activated Neutral Proteinase .
Calcium Activated Protease .
Calcium Dependent Neutral Protease .
Calcium Dependent Neutral Proteinase .
Neutral Protease, Calcium-Activated .
Neutral Protease, Calcium-Dependent .
Neutral Proteinase, Calcium-Activated .
Neutral Proteinase, Calcium-Dependent .
Protease, Ca2+-Activated .
Protease, Calcium-Activated .
Protease, Calcium-Activated Neutral .
Protease, Calcium-Dependent Neutral .
Proteinase, Calcium-Activated Neutral .
Proteinase, Calcium-Dependent Neutral .
Calcium-Activated Neutral Protease .
Calcium-Dependent Neutral Proteinase .
Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including NEUROPEPTIDES; CYTOSKELETAL PROTEINS; proteins from SMOOTH MUSCLE; CARDIAC MUSCLE; liver; platelets; and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4. .
0.42
 
Multiple Endocrine Neoplasia Type 2a .
MEA 2a .
MEA II .
MEA IIa .
MEN II .
MEN IIa .
MEN-2A Syndrome .
MEN2a .
Multiple Endocrine Neoplasia Type 2 .
Multiple Endocrine Neoplasia, Type IIa .
Multiple Endocrine Neoplasms Type 2a .
Pheochromocytoma And Amyloid-Producing Medullary Thyroid Carcinoma .
MEN 2A Syndrome .
MEN-2A Syndromes .
Pheochromocytoma And Amyloid Producing Medullary Thyroid Carcinoma .
MEN 2 .
MEN 2a .
Neoplasia, Multiple Endocrine Type 2a .
Neoplasms, Multiple Endocrine Type 2a .
Sipple Syndrome .
A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease. .
0.40
 
Annexin A1 .
Chromobindin 9 .
Lipocortin 1 .
Renocortin .
Annexin I .
Calpactin II .
Lipocortin I .
Protein of the annexin family exhibiting lipid interaction and steroid-inducibility. .
0.40
 
Cyclic GMP-Dependent Protein Kinase Type II .
cGK II .
cGMP-Dependent Protein Kinase 2 .
cGMP-Dependent Protein Kinase II .
Cyclic GMP Dependent Protein Kinase Type II .
cGMP Dependent Protein Kinase 2 .
cGMP Dependent Protein Kinase II .
A cyclic GMP-dependent protein kinase subtype that is expressed predominantly in INTESTINES, BRAIN, and KIDNEY. The protein is myristoylated on its N-terminus which may play a role its membrane localization. .
0.40